XML 16 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Unaudited Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
LPC Purchase Agreement
At-the-Market Program
March 2020 Offering
February 2021 Offering
Common Stock $0.001 par value
Common Stock $0.001 par value
LPC Purchase Agreement
Common Stock $0.001 par value
At-the-Market Program
Common Stock $0.001 par value
March 2020 Offering
Common Stock $0.001 par value
February 2021 Offering
Additional Paid-In Capital
Additional Paid-In Capital
LPC Purchase Agreement
Additional Paid-In Capital
At-the-Market Program
Additional Paid-In Capital
March 2020 Offering
Additional Paid-In Capital
February 2021 Offering
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning Balance at Dec. 31, 2019 $ 5,835         $ 1         $ 111,509         $ (902) $ (104,773)
Beginning Balance, Shares at Dec. 31, 2019           877,672                      
Proceeds from the issuance of common stock     $ 5,043 $ 1,348                 $ 5,043 $ 1,348      
Proceeds from the issuance of common stock, Shares               232,526 178,776                
Warrant issued       $ 842                   $ 842      
Share issuance costs (506)                   (506)            
Settlement of restricted stock units, Shares           6,831                      
Stock-based compensation 2,021                   2,021            
Foreign currency translation adjustments 209                             209  
Net loss (11,595)                               (11,595)
Ending Balance at Sep. 30, 2020 3,197         $ 1         120,257         (693) (116,368)
Ending Balance, Shares at Sep. 30, 2020           1,295,805                      
Beginning Balance at Jun. 30, 2020 6,396         $ 1         119,807         (521) (112,891)
Beginning Balance, Shares at Jun. 30, 2020           1,288,974                      
Settlement of restricted stock units, Shares           6,831                      
Stock-based compensation 450                   450            
Foreign currency translation adjustments (172)                             (172)  
Net loss (3,477)                               (3,477)
Ending Balance at Sep. 30, 2020 3,197         $ 1         120,257         (693) (116,368)
Ending Balance, Shares at Sep. 30, 2020           1,295,805                      
Beginning Balance at Dec. 31, 2020 3,871         $ 1         123,872         (1,099) (118,903)
Beginning Balance, Shares at Dec. 31, 2020           1,484,362                      
Proceeds from the issuance of common stock   $ 577     $ 8,399         $ 1   $ 577     $ 8,398    
Proceeds from the issuance of common stock, Shares             40,000     744,936              
Warrant issued         $ 2,638                   $ 2,638    
Share issuance costs (1,608)                   (1,608)            
Share issuance costs, Shares           31,958                      
Proceeds from the exercise of warrants 1,318                   1,318            
Proceeds from the exercise of warrants, Shares           81,895                      
Proceeds from the exercise of stock options $ 2                   2            
Proceeds from the exercise of stock options, Shares 214         214                      
Settlement of restricted stock units, Shares           3,428                      
Stock-based compensation $ 3,896                   3,896            
Stock-based compensation, Shares           5,337                      
Foreign currency translation adjustments (26)                             (26)  
Net loss (14,030)                               (14,030)
Ending Balance at Sep. 30, 2021 5,037         $ 2         139,093         (1,125) (132,933)
Ending Balance, Shares at Sep. 30, 2021           2,392,130                      
Beginning Balance at Jun. 30, 2021 8,367         $ 2         138,023         (1,412) (128,246)
Beginning Balance, Shares at Jun. 30, 2021           2,317,772                      
Proceeds from the issuance of common stock   $ 577                   $ 577          
Proceeds from the issuance of common stock, Shares             40,000                    
Share issuance costs (247)                   (247)            
Share issuance costs, Shares           31,958                      
Settlement of restricted stock units, Shares           2,400                      
Stock-based compensation 740                   740            
Foreign currency translation adjustments 287                             287  
Net loss (4,687)                               (4,687)
Ending Balance at Sep. 30, 2021 $ 5,037         $ 2         $ 139,093         $ (1,125) $ (132,933)
Ending Balance, Shares at Sep. 30, 2021           2,392,130